Brain fMRI Predicts Responses to Certolizumab Pegol in RA. an International, Multi-center, Randomized, Double-blind, Placebocontrolled Trial (PreCePRA)

Rech J, Schenker H, Tascilar K, Hagen M, Kleyer A, Simon D, Mendez LV, Schoenau V, Prade J, Sergeeva M, Sulvakumar M, Strobelt S, Konerth L, Behrens F, Baerwald C, Finzel S, Voll R, Hueber A, Rösch J, Feist E, Da Silva JAP, Dörfler A, Damjanov N, Heß A, Schett G (2020)


Publication Type: Conference contribution

Publication year: 2020

Journal

Publisher: WILEY

City/Town: HOBOKEN

Conference Proceedings Title: ARTHRITIS & RHEUMATOLOGY

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Rech, J., Schenker, H., Tascilar, K., Hagen, M., Kleyer, A., Simon, D.,... Schett, G. (2020). Brain fMRI Predicts Responses to Certolizumab Pegol in RA. an International, Multi-center, Randomized, Double-blind, Placebocontrolled Trial (PreCePRA). In ARTHRITIS & RHEUMATOLOGY. HOBOKEN: WILEY.

MLA:

Rech, Jürgen, et al. "Brain fMRI Predicts Responses to Certolizumab Pegol in RA. an International, Multi-center, Randomized, Double-blind, Placebocontrolled Trial (PreCePRA)." Proceedings of the ARTHRITIS & RHEUMATOLOGY HOBOKEN: WILEY, 2020.

BibTeX: Download